Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
26.42
-1.27 (-4.59%)
At close: Dec 5, 2025, 4:00 PM EST
26.41
-0.01 (-0.04%)
After-hours: Dec 5, 2025, 7:53 PM EST
Pharvaris Employees
Pharvaris had 108 employees as of December 31, 2024. The number of employees increased by 26 or 31.71% compared to the previous year.
Employees
108
Change (1Y)
26
Growth (1Y)
31.71%
Revenue / Employee
n/a
Profits / Employee
-$1,778,624
Market Cap
1.72B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PHVS News
- 2 days ago - Pharvaris N.V. (PHVS) Discusses Topline Data From RAPIDe-3 Phase III Study of Deucrictibant for Hereditary Angioedema Transcript - Seeking Alpha
- 3 days ago - Pharvaris Pill Provides Rapid Relief In Patients With Rare Swelling Attacks, Data Shows - Benzinga
- 3 days ago - Pharvaris Announces Positive Topline Data from RAPIDe-3 Pivotal Study Confirming Potential of Deucrictibant for On-Demand Treatment of HAE Attacks - GlobeNewsWire
- 3 days ago - A $68 Million Signal: What General Atlantic Sees in Pharvaris Right Now - The Motley Fool
- 13 days ago - Pharvaris: Biotech With De-Risked Phase 3 Readout Coming, Initiating With A Buy Rating - Seeking Alpha
- 17 days ago - Why Bain Capital Is Selling Shares of This Biotech Stock Now - The Motley Fool
- 24 days ago - Pharvaris Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 26 days ago - Data Supporting the Potentially Differentiated Pharvaris Portfolio Presented at ACAAI 2025 Annual Scientific Meeting - GlobeNewsWire